Manual data processes hindering growth for 87% of scale-ups, new Jitterbit research reveals
Jitterbit, a global leader for empowering transformation through automation, has today revealed the results of its latest research report ‘ Integrate to Scale: How Leading Emerging Enterprises are Automating Their Way to Success ’ – an in-depth survey of Founders and C-suite execs at emerging enterprises in Europe. The research probed business leaders’ perspectives on automation, integration, and the challenges emerging enterprises face in scaling their businesses.
The research, commissioned by Jitterbit and conducted in October 2023 by independent research company Censuswide, surveyed 400 Founders and C-Level executives of venture capital backed companies in the UK, Spain, Germany and Sweden. It reveals a bullish attitude toward growth in the upcoming year, but significant challenges within these businesses managing manual data processes and data silos – a symptom of a lack of business-wide integration.
With venture funding in Europe forecast to fall 38.5% from $83 billion in 2022 to $51 billion in 2023 and pressure on scale-up leaders to deliver greater returns on investment, many emerging enterprises are turning to automation and integration to help drive efficiencies and growth.
Growth ambitions for the upcoming year
- 78% of leaders of scale-ups surveyed across Europe plan to grow their business by at least 40% in the next 12 months
- 41% of founders surveyed plan to grow their companies by more than 60%
- 82% of all respondents agree business automation is key to scaling their business
What’s hindering growth
- 87% of all respondents blame data silos and manual data processes (where employees – not integrations – move data between platforms and solutions within the business) for hindering growth by agreeing that they are a pain point in their business
- Looking at manual data processes, 38% of respondents reported having between 26-50 manual processes within the business, and 55% reported having between 50-100 manual data processes to manage
- 78% would like to reduce the number of manual data processes in their business
Another source of pain for emerging enterprises is the lack of integration of all of the software solutions, platforms and technologies that they employ. An overwhelming majority – 74% of all respondents – agreed that their company’s mix of software solutions, platforms and technologies are not fully integrated. Moreover, nearly 76% responded that they find it difficult not only to integrate new software, but to manage those integrations as well.
To alleviate these challenges, many companies are turning to a variety of different integration solutions such as Integration Platform as a Service (iPaaS) (56%), as well as single point connector workflow automation tools (52%) and low code application development platforms (36%) to reduce operational bottlenecks, enhance efficiency, and ultimately improve their overall productivity.
Integration solutions are particularly popular with businesses wanting to eliminate manual data processes with 43% of respondents citing this as their top reason for using them. A further 28% are using integration software to cut down on costs.
Joost De Bot, Senior Vice President & General Manager, EMEA at Jitterbit, said:
“It’s positive to see that business leaders are still confident about growth and 82% of these emerging enterprise companies recognise business automation is key to achieving it. However, it’s clear that one of the thorniest challenges they face in automating operations is the sheer number of manual data processes that they still employ within their businesses. These manual processes are not only time-consuming and inefficient, but are typically error-prone.
Successful enterprises of the future must act swiftly to adopt and automate their business processes to stay ahead. There’s no doubt that leveraging integration tools and removing manual processes will play a crucial role in enabling emerging enterprise players to scale the right way and remain competitive in an increasingly competitive market where capital is harder to raise.”
The full report ‘ ‘ Integrate to Scale: How Leading Emerging Enterprises are Automating Their Way to Success ’ can be downloaded here: https://www.jitterbit.com/event/jitterbit-at-websummit-2023/
Ends.
Notes to editors.
About the Research
The research was commissioned by Jitterbit and conducted by Censuswide with 400 Founders and C Level Executives (18+) at Emerging Enterprises companies across the UK, Spain, Germany and Sweden between 17.10.23 to 24.10.23. Censuswide abide by and employ members of the Market Research Society which is based on the ESOMAR principles and are members of The British Polling Council.
About Jitterbit, Inc.
Jitterbit empowers business transformation with low-code enterprise solutions for integration and application development. Jitterbit combines and simplifies the power of iPaaS, APIM, EDI, and LCAP to amplify the value of on-premise, cloud-based, and SaaS systems and accelerate the digital journey. Organizations around the globe rely on Jitterbit’s experience and expertise to help them automate critical business processes and build applications to future proof their business. Learn how Jitterbit helps people work happier at www.jitterbit.com or follow us on LinkedIn.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20231112987357/en/
Contact information
Cat Lenheim, ThoughtLDR
cat@thoughtldr.com
+44 7511 117587
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
30 Peer-Reviewed Studies Highlight Statistically Significant Health Benefits of Almased16.7.2025 10:15:00 EEST | Press release
Two recent, peer-reviewed clinical studies have found that Almased, a high-protein, low-glycemic meal replacement, delivers significant health benefits ranging from weight loss and improved metabolic health to anti-aging effects and enhanced quality of life. Both reviews synthesize 30 peer-reviewed clinical studies across three decades of scientific research, confirming that Almased is effective and safe for weight reduction, preservation of lean muscle mass, and cardiovascular health. The 2025 review in the American Journal of Biomedical Science & Research highlighted Almased’s efficacy and safety for wide groups of people including individuals seeking weight loss, those with metabolic syndrome or fatty liver, older adults needing to preserve muscle mass, and athletes or healthy-weight individuals who require additional high-quality protein. This review also discusses how Almased’s patented fermentation process produces over 80 bioactive peptides, including 2 times the average daily i
Skechers AERO Series Opens New Chapter of Technical Running Innovation16.7.2025 10:00:00 EEST | Press release
Skechers Performance opens a new chapter of running innovation with the arrival of the Skechers AERO series. Named for the aerodynamic feel of the design, Skechers AERO represents the latest evolution of technical running shoes from the brand. The collection is engineered to deliver an exhilarating blend of speed, style and comfort to help runners cut through the wind and push beyond their personal bests while logging miles. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250716754749/en/ Introducing the Skechers AERO Series of technical running shoes: Skechers AERO Burst, Skechers AERO Spark, and Skechers AERO Tempo (L-R). “Recently launched in North America and Asia, the AERO Series leverages innovative technologies to elevate our signature comfort that’s now available to runners in Europe,” said Ben Stewart, Vice President, Skechers Technical Performance Division. “An evolution of our legacy in running, Skechers AERO was d
The Future of Connectivity Starts Here: Network X Returns to Paris October 14 - 1616.7.2025 10:00:00 EEST | Press release
Network X 2025 - the only event that brings the fixed and mobile markets together - returns to Paris Expo Porte de Versailles October 14 - 16. Built for telecom's top players, this annual show drives business model innovation and monetisation of next-generation fixed, mobile, satellite and transport networks through AI and cloud. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250716595903/en/ Speaker on Headliners Stage at Network X 2024 New to Network X in 2025 are specialty events designed to deliver expert insights on trending topics including Data Center World and two Expo Stages for Fixed-Line and Mobile. More than 5,500 telco network infrastructure professionals will gather alongside 1,500 telcos to learn from six program tracks highlighting the latest advancements in Fibre, Wi-Fi Networks and Services, IP and Optical Transport, Mobile Networks, Mobile Services, and Data Centres. “Network X is more than a conference—it
4Moving Biotech Enrolls First Patient in Phase 2a Trial of 4P004, a Potential First-in-Class GLP-1 Therapy for Knee Osteoarthritis16.7.2025 08:00:00 EEST | Press release
4Moving Biotech (4MB), a spin-off of 4P-Pharma dedicated to developing first-in-class treatments that modify the natural course of knee osteoarthritis (OA), today announced that the first patient has been enrolled in Phase 2a clinical trial, INFLAM MOTION. The study will evaluate 4P004, an intra-articular GLP-1 analog, as a potential first-in-class therapeutic candidate for knee osteoarthritis. INFLAM MOTION is a multicenter, randomized, double-blind, placebo-controlled Phase 2a trial planned to be conducted across Europe, the United States, and Canada. A total of 129 patients worldwide diagnosed with knee OA will be enrolled to evaluate, for the first time in humans, the efficacy of 4P004. “Enrolling our first patient is a pivotal step toward rewriting the treatment paradigm for knee osteoarthritis,” said Professor Francis Berenbaum, MD, PhD, Chief Medical Officer at 4Moving Biotech. “Almost 600 million people live with OA, yet no disease-modifying therapy has been done to patients. B
Belkin Achieves Qi2.2 Certification for Its Upcoming Products, Unlocking the Future of 25W Wireless Charging15.7.2025 20:06:00 EEST | Press release
Belkin, a leading consumer electronics brand for over 40 years, today announced it has received official Qi2.2 certification from the Wireless Power Consortium (WPC) for its upcoming products. As one of the first accessory brands to deliver Qi2.2-certified devices, Belkin is helping bring the next generation of wireless charging to market – enabling faster wireless charging speeds, broader compatibility, and improved performance for consumers. Belkin’s close partnership with the WPC since 2015 has been instrumental in bringing these advancements to consumers. As an early adopter and long-time contributor to WPC standards, Belkin was selected as one of a small group of trusted manufacturers to test and certify Qi2.2 products ahead of the broader industry rollout. All Belkin products undergo rigorous safety, quality, and performance testing. The company’s global headquarters includes WPC certified test equipment and state-of-the-art test labs dedicated to full product lifecycle validatio
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom